In order to assess the prognostic relevance of CCL2 gene expression in patients with neuroblastoma, RNA expression profiles, tumor biological characteristics, and clinical outcomes were obtained from available datasets previously analyzed by Cangelosi et al. and Asgharzadeh et al.16–18. The gene discussed is CCL2; the disease is neuroblastoma.